Wall Street brokerages expect that Nu Skin Enterprises, Inc. (NYSE:NUS) will announce sales of $702.28 million for the current fiscal quarter, according to Zacks Investment Research. Three analysts have issued estimates for Nu Skin Enterprises’ earnings, with estimates ranging from $698.40 million to $705.04 million. Nu Skin Enterprises reported sales of $612.37 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 14.7%. The business is expected to announce its next earnings results on Wednesday, August 4th.
On average, analysts expect that Nu Skin Enterprises will report full-year sales of $2.85 billion for the current financial year, with estimates ranging from $2.84 billion to $2.85 billion. For the next financial year, analysts forecast that the company will report sales of $2.94 billion, with estimates ranging from $2.83 billion to $3.03 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that follow Nu Skin Enterprises.
Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings results on Wednesday, May 5th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.72 by $0.19. Nu Skin Enterprises had a net margin of 6.54% and a return on equity of 19.18%. The company had revenue of $677.03 million during the quarter, compared to the consensus estimate of $633.26 million.
A number of equities analysts have recently commented on NUS shares. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Nu Skin Enterprises from $57.00 to $64.00 and gave the stock a “hold” rating in a report on Thursday, May 6th. Jefferies Financial Group upped their price target on Nu Skin Enterprises from $60.00 to $66.00 and gave the company a “buy” rating in a research report on Tuesday, February 2nd. Finally, DA Davidson downgraded Nu Skin Enterprises from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $71.00 to $58.00 in a research report on Friday, February 12th. Six analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $57.00.
In other news, insider Joseph Y. Chang sold 626 shares of the stock in a transaction dated Tuesday, March 9th. The shares were sold at an average price of $51.55, for a total transaction of $32,270.30. Following the transaction, the insider now owns 17,942 shares of the company’s stock, valued at approximately $924,910.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, General Counsel D Matthew Dorny sold 12,400 shares of the firm’s stock in a transaction dated Monday, March 1st. The shares were sold at an average price of $52.09, for a total value of $645,916.00. Over the last quarter, insiders sold 28,074 shares of company stock valued at $1,518,765. 3.40% of the stock is currently owned by corporate insiders.
A number of hedge funds have recently bought and sold shares of the stock. Norges Bank acquired a new stake in Nu Skin Enterprises in the fourth quarter valued at approximately $46,393,000. SummerHaven Investment Management LLC bought a new position in Nu Skin Enterprises during the 4th quarter valued at $511,000. Wasatch Advisors Inc. bought a new position in Nu Skin Enterprises during the 1st quarter valued at $23,214,000. Renaissance Technologies LLC boosted its holdings in Nu Skin Enterprises by 15.6% during the 4th quarter. Renaissance Technologies LLC now owns 2,723,596 shares of the company’s stock worth $148,790,000 after acquiring an additional 367,096 shares during the last quarter. Finally, AQR Capital Management LLC grew its stake in shares of Nu Skin Enterprises by 37.9% in the 1st quarter. AQR Capital Management LLC now owns 1,154,622 shares of the company’s stock worth $61,068,000 after acquiring an additional 317,092 shares in the last quarter. 73.75% of the stock is currently owned by institutional investors and hedge funds.
Nu Skin Enterprises stock opened at $59.77 on Friday. The stock has a 50-day moving average price of $54.78 and a two-hundred day moving average price of $53.84. Nu Skin Enterprises has a 12 month low of $35.36 and a 12 month high of $63.85. The company has a market capitalization of $2.99 billion, a PE ratio of 20.12, a P/E/G ratio of 2.03 and a beta of 1.37. The company has a current ratio of 1.66, a quick ratio of 1.08 and a debt-to-equity ratio of 0.38.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 9th. Investors of record on Friday, May 28th will be paid a dividend of $0.38 per share. The ex-dividend date of this dividend is Thursday, May 27th. This represents a $1.52 annualized dividend and a yield of 2.54%. Nu Skin Enterprises’s dividend payout ratio is currently 49.03%.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products.
Featured Story: Analyst Ratings Trading
Get a free copy of the Zacks research report on Nu Skin Enterprises (NUS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com